Title : Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation.

Pub. Date : 2020 Dec 8

PMID : 33323826






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation: a single-center analysis. Decitabine tumor protein p53 Homo sapiens